Research Topic: gene expression

In-ovo injection of Bacillus subtilis, raffinose, and their combinations enhances hatchability, gut health, nutrient transport- and intestinal function-related genes, and early development of broiler chicks

Researchers injected newly developing chicken eggs with beneficial bacteria (Bacillus subtilis) and a prebiotic substance (raffinose) to improve chick health. The treatment enhanced egg hatchability, improved chick weight, reduced harmful bacteria in the gut, and strengthened intestinal function. This approach shows promise as a natural alternative to antibiotics in poultry farming.

Read More »

The Transformation and Protein Expression of the Edible Mushroom Stropharia rugosoannulata Protoplasts by Agrobacterium-tumefaciens-Mediated Transformation

Scientists developed a genetic engineering technique to modify king stropharia (a cultivated edible mushroom) by inserting foreign genes into its cells. This breakthrough allows researchers to study how the mushroom grows and produces beneficial compounds. The technique uses a bacterium called Agrobacterium tumefaciens to naturally deliver genes into mushroom cells, similar to how it infects plants. This advancement could lead to improved cultivation practices and enhanced nutritional or medicinal properties.

Read More »

Glyoxalase 1 Inducer, trans-Resveratrol and Hesperetin–Dietary Supplement with Multi-Modal Health Benefits

A dietary supplement combining trans-resveratrol and hesperetin activates a cellular defense mechanism called Nrf2, which increases production of an enzyme (Glo1) that helps eliminate harmful byproducts of sugar metabolism. This supplement improved multiple aspects of health in studies, including better blood sugar control, reduced inflammation, and improved liver function. The combination works better than either ingredient alone, and the trans form of resveratrol is much more effective than the cis form.

Read More »

Transcriptome and Metabolome Reveal Accumulation of Key Metabolites with Medicinal Properties of Phylloporia pulla

Scientists studied a medicinal fungus called Phylloporia pulla to understand which health-promoting compounds it produces and how it makes them. Using advanced genetic and chemical analysis tools, they discovered the fungus produces beneficial compounds like steroids and triterpenoids that have anti-inflammatory and anti-cancer properties, with production peaking around the middle of the fungus’s growth cycle. They identified six key genes that control the production of celastrol, a particularly valuable compound with potential to treat diseases like Alzheimer’s and cancer. This research helps explain why this fungus has been used traditionally in medicine and provides guidance for growing it to maximize production of these beneficial compounds.

Read More »

Antimicrobial and prebiotic properties of Weissella confusa B4-2 exopolysaccharide and its effects on matrix metalloproteinase genes expression

Researchers discovered that a bacterium called Weissella confusa produces a sticky substance (exopolysaccharide) that has multiple health benefits. This substance fights harmful bacteria, acts as an antioxidant, helps heal wounds, and may slow down skin aging by reducing proteins that break down collagen. Because this bacterium produces much more of this substance than other commonly studied bacteria, it could be used in food preservation, health supplements, and anti-aging skincare products.

Read More »

Fatty acid synthesis: A critical factor determining mycelial growth rate in Pleurotus tuoliensis

Researchers studied why Pleurotus tuoliensis mushrooms grow slowly compared to other oyster mushroom species. They found that a key enzyme called acetyl-CoA carboxylase, which controls fat production in the mushroom cells, directly affects how fast the mycelium grows. By increasing this enzyme’s activity and providing nutrients that help fat-making, scientists were able to boost mycelial growth rates significantly, offering new strategies to improve commercial cultivation of these delicious mushrooms.

Read More »

Analysis of Gene Regulatory Network and Transcription Factors in Different Tissues of the Stropharia rugosoannulata Fruiting Body

Researchers analyzed the gene activity patterns across different parts of wine cap mushrooms (Stropharia rugosoannulata) to understand how the fruiting body develops. By examining gene expression in six different tissue types, they identified which genes are active in each tissue and what biological processes they control. This foundational knowledge can help improve mushroom cultivation techniques and production efficiency.

Read More »

Mitigating nickel-induced toxicity: the protective role of native probiotic strains on oxidative stress and inflammatory pathways in mice lung tissues

This study examined how probiotic bacteria can protect lung tissue from damage caused by nickel exposure. Researchers gave mice nickel to cause oxidative stress and inflammation, then treated them with beneficial bacteria from four probiotic strains. The probiotics successfully reduced oxidative stress markers and inflammatory responses in the lung tissue by activating protective genes and deactivating inflammatory genes. This research suggests that probiotics could be a natural way to prevent lung damage from heavy metal exposure.

Read More »

Post-Harvest Quality Changes and Molecular Responses of Epidermal Wax in ‘Munage’ Grapes with Botrytis cinerea Infection

‘Munage’ grapes from Xinjiang are susceptible to a fungus called Botrytis cinerea that causes gray mold during storage. The fungus dissolves the protective waxy coating on the grape surface, leading to faster deterioration. The study identified specific genes and proteins that control wax production, which could help scientists develop better storage methods and disease prevention strategies to keep grapes fresher longer.

Read More »

Identification of Blood Biomarkers of Psilocybin-Assisted Therapy Treatment Response for Generalised Anxiety Disorder

Researchers studied how psilocybin-assisted therapy works for people with anxiety disorders by examining blood samples from patients who responded well to treatment versus those who didn’t. They identified four genes whose expression patterns could help predict which anxiety patients would benefit from psilocybin therapy before starting treatment. This breakthrough could help doctors avoid giving intensive treatment to patients unlikely to respond and instead direct them toward more effective alternatives.

Read More »
Scroll to Top